Blockchain Registration Transaction Record

Annovis Bio to Unveil Alzheimer’s and Parkinson’s Trial Updates in Live Webcast

Annovis Bio announces a live webcast on June 24, 2025, to discuss Phase 3 Alzheimer’s trial and FDA feedback on Parkinson’s program. Learn more about their innovative therapies.

Annovis Bio to Unveil Alzheimer’s and Parkinson’s Trial Updates in Live Webcast

This news is crucial for patients, families, and investors as it highlights Annovis Bio's advancements in treating neurodegenerative diseases. The live webcast offers a rare opportunity to gain insights into potential breakthroughs in Alzheimer’s and Parkinson’s therapies, which could significantly improve the quality of life for millions affected by these conditions. The FDA feedback and Phase 3 trial updates are pivotal steps toward bringing innovative treatments to market.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x77dad19cc63019667c94a96ce9c67c98328c910ee858feb8324502390e7ce717
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintdeepN28b-9996171f13c64c2eedb5bc964a8fc901